| 摘要 |
1. Process for the specific determination of pancreatic alpha-amylase in body fluids, especially in serum, plasma, duodenal juice or urine, by reaction with a system for the detection of alpha-amylase in the presence of a monoclonal antibody which inhibits salivary alpha-amylase, characterised in that, as inhibitor, there is used a first monoclonal antibody which specifically inhibits the salivary enzyme by more than 70% but less than 97%, in combination with a second monoclonal anti-salivary alpha-amylase antibody which inhibits this enzyme by less than 10%. |
